Tandem Diabetes Care Inc

TNDMNASDAQ · USD
15.22USD0.00 (-7.09%)
4710

Tandem Diabetes Care Inc (TNDM) Wheel Strategy

TNDM wheel strategy scan found 20 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 89.3%.

Read more

Running a TNDM wheel strategy lets you generate consistent premium income on Tandem Diabetes Care Inc while setting your own entry and exit prices on the underlying. Tandem Diabetes Care Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own TNDM, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best TNDM wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on TNDM, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable TNDM wheel from a losing one.

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin.

It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the TNDM wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your TNDM wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.

Oct 16, 202616.00$0.60$0.90-0.412318%52.7%89.3%5
Nov 20, 202613.00$0.15$1.35-0.235818%77.0%65.4%12
Oct 16, 202615.00$0.05$0.58-0.282318%67.2%60.8%11
Nov 20, 202615.00$0.70$1.30-0.325818%58.4%54.5%33
Feb 19, 202715.00$1.95$2.78-0.3214918%50.9%45.3%34
Jan 15, 202715.00$1.30$1.95-0.3311418%52.9%41.6%6
Nov 20, 202614.00$0.35$0.93-0.255818%67.9%41.6%17
Jan 15, 202713.00$0.70$1.68-0.2411418%67.3%41.3%518
Feb 19, 202714.00$1.60$2.03-0.2814918%57.1%35.4%29
Jan 15, 202714.00$0.90$1.53-0.2711418%60.0%34.9%10

As of September 23, 2026

Run the Wheel on TNDM With Confidence

Find the best TNDM wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.

Start your 14-day free trial